SPRING PHARMACEUTICAL GROUP, INC. — Revenue by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/7d0e8b84-adb0-4c2c-af2d-0068ada30ccf/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2017 | $64.9M | 2017-04-01 – 2018-03-31 | evidence 0001096906-18-000372 |
| FY 2016 | $56.5M | 2016-04-01 – 2017-03-31 | evidence 0001096906-17-000447 |
| FY 2015 | $47.8M | 2015-04-01 – 2016-03-31 | evidence 0001096906-17-000447 |
| FY 2014 | $37.9M | 2014-04-01 – 2015-03-31 | evidence 0001096906-16-001729 |
| FY 2013 | $34.1M | 2013-04-01 – 2014-03-31 | evidence 0001096906-15-000749 |
| FY 2012 | $33.1M | 2012-04-01 – 2013-03-31 | evidence 0001144204-13-037466 |
| FY 2011 | $37.6M | 2011-04-01 – 2012-03-31 | evidence 0001144204-12-038963 |
| FY 2010 | $33.5M | 2010-04-01 – 2011-03-31 | evidence 0001144204-12-033955 |
| FY 2009 | $32.0M | 2009-04-01 – 2010-03-31 | evidence 0001144204-12-033955 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
SPRING PHARMACEUTICAL GROUP, INC. — all facts · Net Income · Operating Income